Hikma Pharmaceuticals USA Inc. recalls Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 0772
Recalled August 17, 2022 · FDA recall D-1307-2022 · Hikma Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. · FDA Class II
Units
4,739,000 vials
Sold at
Nationwide in the USA
Description
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Product
Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6044-25, Vial NDC# 0641-6044-01
Manufacturer(s)
Hikma Pharmaceuticals USA Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →